Trimodality therapy for patients with stage III non-small-cell lung cancer: A comprehensive surveillance, epidemiology, and end results analysis

Trimodality therapy for patients with stage III non-small-cell lung cancer: A comprehensive surveillance, epidemiology, and end results analysis

Purpose: Debate exists regarding the optimal management for patients with stage III non-small-cell lung cancer (NSCLC). Recent inclusion of chemotherapeutic data in the Surveillance, Epidemiology, and End Results (SEER) database has made it possible to identify patients with NSCLC who received chemo...

Full description

Bibliographic Details
Main Authors:	Vincent P. Grzywacz, Thomas J. Quinn, Muayad F. Almahariq, Zaid A. Siddiqui, Sang W. Kim, Thomas M. Guerrero, Craig W. Stevens, Inga S. Grills
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Cancer Treatment and Research Communications
Subjects:	Database Survival Locally advanced NSCLC Chemoradiation Surgery
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468294222000612

Similar Items

A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC
by: Christopher A. Lemmon, MD, et al.
Published: (2022-07-01)

Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC
by: Narek Shaverdian, MD, et al.
Published: (2021-07-01)

Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study
by: Jiyun Lee, et al.
Published: (2024-04-01)

The role of chemotherapy in the management of olfactory neuroblastoma: A 40‐year surveillance, epidemiology, and end results registry study
by: Ryan J. Brisson, et al.
Published: (2021-06-01)

Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III Non-Small-Cell Lung Cancer: Results of KINDLE-Vietnam Cohort
by: Tu Van Dao, et al.
Published: (2022-05-01)

Moderately Escalated Hypofractionated (Chemo)Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer
by: Vittorio eDonato, et al.
Published: (2013-11-01)

Induction chemotherapy in nasopharyngeal carcinoma- A systematic review of phase III clinical trials
by: Farida Nazeer, et al.
Published: (2022-01-01)

A Retrospective Evaluation of Clinical Profile of Second Primary Head and Neck Cancer
by: Paramjeet Kaur, et al.
Published: (2016-10-01)

Trimodality Treatment of Superior Sulcus Non-Small Cell Lung Cancer: An Institutional Series of 47 Consecutive Patients
by: Witold Rzyman, et al.
Published: (2023-04-01)

Treatment Patterns for Patients With Unresected Stage III NSCLC: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database
by: Shijie Shang, et al.
Published: (2022-06-01)

Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer—A Secondary Analysis of the PET Plan Trial
by: Eleni Gkika, et al.
Published: (2020-11-01)

The role of chemoradiotherapy and immunotherapy in stage III NSCLC
by: Zsuzsanna Orosz, et al.
Published: (2024-04-01)

Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study
by: Jonathan Garnier, et al.
Published: (2020-03-01)

Consolidation treatment of durvalumab after chemoradiation in real‐world patients with stage III unresectable non‐small cell lung cancer
by: Chia‐Hsun Chu, et al.
Published: (2020-06-01)

Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer
by: Ke Nie, et al.
Published: (2022-06-01)

Management of Advanced Squamous Cell Carcinoma of the Vulva
by: Linda J. Rogers
Published: (2021-12-01)

Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?
by: Jen-Hao Yeh, et al.
Published: (2022-06-01)

Long-Term Total Neoadjuvant Therapy Leads to Impressive Response Rates in Rectal Cancer: Results of a German Single-Center Cohort
by: Georg W. Wurschi, et al.
Published: (2023-05-01)

IMRT in the treatment of locally advanced or inoperable NSCLC in the pre-durvalumab era: clinical outcomes and pattern of relapses, experience from the Oscar Lambret Center
by: Thomas Le Roy, et al.
Published: (2023-09-01)

Predictors of tumor response to neoadjuvant chemoradiation in locally advanced rectal cancer Egyptian patients
by: Mohamed M. Elmessiry, et al.
Published: (2015-02-01)

Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis
by: Chen M, et al.
Published: (2019-01-01)

A prospective randomised study on comparison of weekly versus 3 weekly cisplatin chemotherapy as an adjunct to radiotherapy in treatment of carcinoma of the uterine cervix
by: V L Anusha Konakalla, et al.
Published: (2018-01-01)

The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas
by: S.J. Rogers, et al.
Published: (2021-03-01)

Efficiency of Cisplatin Based Concurrent Chemoradiation in Stages III & IV Head & Neck Squamous Cell Carcinoma
by: Syeda Uzma Naqvi, et al.
Published: (2016-08-01)

Efficiency of Cisplatin Based Concurrent Chemoradiation in Stages III & IV Head & Neck Squamous Cell Carcinoma
by: Syeda Uzma Naqvi, et al.
Published: (2016-08-01)

Efficiency of Cisplatin Based Concurrent Chemoradiation in Stages III & IV Head & Neck Squamous Cell Carcinoma
by: Kulsoom Begum, et al.
Published: (2016-08-01)

Effect of Lymphopenia on Tumor Response and Clinical Outcomes Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer
by: Deck J, et al.
Published: (2023-05-01)

Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC
by: Johan F. Vansteenkiste, MD, PhD, et al.
Published: (2024-03-01)

Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India
by: Sushma Agrawal
Published: (2013-01-01)

Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapyCentral MessagePerspective
by: Andrew Tang, MD, MS, et al.
Published: (2022-06-01)

Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
by: Lei Lei, et al.
Published: (2021-01-01)

Interaction between the Number of Chemotherapy Cycles and Brachytherapy Dose/Volume Parameters in Locally Advanced Cervical Cancer Patients
by: Alexandre Escande, et al.
Published: (2020-06-01)

Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate
by: Kim van Kol, et al.
Published: (2021-12-01)

Durvalumab in the treatment of locally advanced non-small cell lung cancer after chemoradiotherapy in a real practice
by: Dina D Sakaeva, et al.
Published: (2019-09-01)

Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center
by: Stephane Thibodeau, et al.
Published: (2023-01-01)

An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy
by: Saurav Verma, et al.
Published: (2024-03-01)

Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study
by: Christopher M. Jones, et al.
Published: (2022-11-01)

Combined chemoradiotherapy regimens and their effectiveness in the treatment of patients with non-small-cell unresectable stage III lung cancer: review of literature
by: N. V. Marinichenko, et al.
Published: (2019-06-01)

Small cell neuroendocrine carcinoma of the uterine cervix (SCNEC): a case report and review
by: Puja Agung Antonius, et al.
Published: (2021-07-01)

Extraosseous Ewing’s tumor of lateral abdominal wall
by: Nikhil Gupta, et al.
Published: (2011-11-01)